Goldman Sachs
MBIO icon

Goldman Sachs’s Mustang Bio MBIO Stock Holding History

Goldman Sachs’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-265
Closed -$2.35K – 6278
2024
Q4 		$2.35K Buy
+265
New +$2.92K ﹤0.01% 5972
2023
Q2 		– Sell
-89
Closed -$24.3K – 5939
2023
Q1 		$24.3K Sell
89
-15
-14% -$6.15K ﹤0.01% 5647
2022
Q4 		$30.7K Sell
104
-37
-26% -$12.6K ﹤0.01% 5654
2022
Q3 		$50K Sell
141
-64
-31% -$29.7K ﹤0.01% 5802
2022
Q2 		$90K Sell
205
-45
-18% -$24.9K ﹤0.01% 5893
2022
Q1 		$189K Sell
250
-137
-35% -$113K ﹤0.01% 5911
2021
Q4 		$483K Buy
387
+56
+17% +$90.4K ﹤0.01% 5413
2021
Q3 		$669K Buy
331
+224
+209% +$481K ﹤0.01% 5020
2021
Q2 		$266K Sell
107
-448
-81% -$1.1M ﹤0.01% 5586
2021
Q1 		$1.38M Buy
555
+291
+110% +$865K ﹤0.01% 4350
2020
Q4 		$748K Sell
264
-138
-34% -$330K ﹤0.01% 4386
2020
Q3 		$949K Buy
402
+238
+145% +$587K ﹤0.01% 4115
2020
Q2 		$390K Buy
164
+150
+1,071% +$351K ﹤0.01% 4502
2020
Q1 		$28K Buy
+14
New +$35.9K ﹤0.01% 5100
2018
Q3 		– Sell
-73
Closed -$378K – 5711
2018
Q2 		$378K Sell
73
-39
-35% -$246K ﹤0.01% 4669
2018
Q1 		$918K Buy
112
+97
+647% +$826K ﹤0.01% 4110
2017
Q4 		$131K Buy
+15
New +$116K ﹤0.01% 5640

Other funds holding MBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs's MBIO Position: Q1 2025 in Review

Goldman Sachs sold out of Mustang Bio (MBIO) in Q1 2025, closing a stake of 265 shares — an estimated $2.35K sold.

Goldman Sachs first reported a position in MBIO in Q4 2017 and held it in 17 quarters. The position peaked at $1.38M in Q1 2021. 16 funds tracked by Wall St. Rank hold MBIO as of Q1 2025.

  • Goldman Sachs reported no remaining Mustang Bio position as of Q1 2025 after selling out during the quarter.
  • Goldman Sachs sold 265 Mustang Bio shares in Q1 2025, an estimated $2.35K.
  • Goldman Sachs first reported a position in Mustang Bio in Q4 2017 and held it in 17 quarters.
  • Goldman Sachs's Mustang Bio position peaked at $1.38M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2025.

Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.